Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access scheme ...

Yarilet Perez is an experienced multimedia journalist and fact-checker with a Master of Science in Journalism. She has worked in multiple cities covering breaking news, politics, education, and more.

Only two rivals stuck around to face 2-year-old colt Mailata in the $75,000 Future Stars male division at Parx on Tuesday. Both runners paid the price, as the 1-5 favorite pulled away at will to win ...